by Bill Malloy | Jun 29, 2022 | Uncategorized
A clinical trial at the University of Cincinnati has found that adding a newly developed immunotherapy drug to standard treatment methods could improve survival rates for head and neck cancer patients. The trial was led by Trisha Wise-Draper, MD, and published in the...
by Bill Malloy | Jun 13, 2022 | Uncategorized
An international study researching innovations in the treatment of colorectal cancer was bolstered in early February by a five-year renewal and $10 million in new funding. Based at the Huntsman Cancer Institute at the University of Utah, the ColoCare Study commenced...
by Bill Malloy | Jun 6, 2022 | Uncategorized
A team of stem cell scientists from Cedars-Sinai Medical Center in Los Angeles recently made two discoveries that could have major implications for cancer treatment. Researchers in the first study made a discovery that could drastically improve the efficiency of...
by Bill Malloy | May 9, 2022 | Health, Pharmaceuticals, Scientists, Uncategorized
A potential cancer immunotherapy treatment has been developed by researchers at Purdue University’s College of Pharmacy. Led by Zhong-Yin Zhang, the researchers are continuing to develop the immunotherapy treatment, which is based on an enzyme mutation. The team of...
by Bill Malloy | Apr 9, 2022 | Uncategorized
Project management company Asana went public in September 2020, and despite some volatility, its value has risen significantly since then. This San Francisco-based tech newcomer’s market arrival was highly anticipated in the industry, and as it continues to grow, it...
by Bill Malloy | Nov 18, 2021 | Uncategorized
Cancer has affected the lives of the majority of Americans. According to a CBS News poll, 54% of Americans have either been diagnosed with cancer themselves, or have a family member who has been diagnosed. Brain cancer is the most common type of cancer among children...